Uncategorized

Search

Recruitment Status

New USA trial results on the “need for chemotherapy”

Professor Arlene Chan and Dr Chris Lomma on “New USA trial results on the “need for chemotherapy”

Read More

Professor Arlene Chan Awarded the Order of Australia for the 2018 Queen’s Birthday Honours

BCRC-WA have welcomed the announcement that Professor Arlene Chan has been awarded the Order of Australia for the 2018 Queen’s Birthday Honours. Professor Chan has been recognised for her ‘significant service to medicine in the field of oncology, particularly breast cancer support, diagnosis and treatment’. Hear Professor Arlene Chan discuss breast cancer research, our Offspring…

Read More

Participate in a BCRC-WA Focus Group

We are committed to providing all our patients the best quality care. So we can achieve this, we would like to invite you to come and share your opinions about our services. An independent facilitator will run two group sessions  where you can voice your thoughts in a safe and judgement-free environment. Dates: Tuesday  12th June…

Read More

BCRC-WA Reshaping the future of breast cancer care

Breast Cancer Research Centre -WA are reshaping the future of breast cancer care. Find out more about BCRC-WA as we work towards our vision for a fully integrated breast cancer centre.

Read More

The Sunday Times- Perth oncologist’s cancer ‘cure’ leaves mums smiling

“There is definitely hope for women with advancements in breast cancer research and probably the biggest hope is for better and less toxic drugs which will be able to keep women with metastatic breast cancer living for many years with a chronic disease” – Professor Arlene Chan in the Sunday Times. Read More in the…

Read More

Ten Eye Witness News: Professor Arlene Chan & Shereen Jolly on Neratinib

In May, BCRC-WA welcomed the announcement that the Food and Drug Administration (the licencing body for new medications in the USA) had given approval for use of the drug Neratinib. This is a drug used exclusively for patients with HER2-positive breast cancer. Neratinib, an oral drug, was evaluated in the ExteNET trial which commenced 8…

Read More

89.7FM interviews BCRC-WA Chief Executive Officer Carmelo Arto

April 2017

Read More

Channel 9 Interview with Prof Arlene Chan and Narelle Helsemans

April 2017

Read More

Prof Arlene Chan inducted

WA Women’s Hall of Fame 2017

Read More

ABC Radio Interview with Prof Arlene Chan

An inspiring interview

Read More